JamesBrey / iStockphoto.com
The number of Abbreviated New Drug Application (ANDA) disputes filed in 2016 represented a drop for the first time in three years, the newly published “Hatch-Waxman ANDA Litigation Report 2017” has said.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
ANDA, FDA, NDA, patent, litigation, Lex Machina, Hatch-Waxman ANDA Litigation Report 2017
